Editorial Board for section 'Drug Targeting and Design'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Institute of Applied Biotechnology, University of Applied Science Biberach, 88400 Biberach, Germany
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
Interests: CNS drug delivery; intranasal delivery; hydrogels for mucosal delivery; antibody and protein engineering; delivery of monoclonal antibodies; safety and immune interaction; assay and model development (in vitro, ex vivo and in vivo); proof-of concept studies; mechanism-of-action studies; neurodegenerative diseases; neurobiology
Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden
Interests: antibody engineering; antibody; chemical conjugation; radionuclide molecular imaging; radiopharmaceuticals; alternative scaffolds proteins; protein engineering; in tumor targeting
Interests: antibody engineering; antibody; chemical conjugation; radionuclide molecular imaging; radiopharmaceuticals; alternative scaffolds proteins; protein engineering; in tumor targeting
